HIV-1 Genotype (RTI, PI, Integrase Inhibitors)

Last Modified: 4/8/2019 1:14:38 PM


Specimen Requirements:

3.0 mL FROZEN Plasma from a Lavender Top Tube - EDTA in a Plastic Vial
Minimum Volume: 1.2 mL Plasma
Transport & Storage: Temperature/Stability: 24 hours Ambient
6 days Refrigerated
42 days Frozen (Transport)

Freshly drawn specimens (whole blood) may be stored at 2°C to 25°C for up to 24 hours prior to centrifugation.
Rejection Criteria: Plasma received frozen in the plasma preparation tube (PPT) • Serum • Whole blood greater than 24 hours old • Frozen whole blood
Reference Range: Refer to Interpretive Results
Methodology: Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) • Sequencing
Clinical Significance: Identify drug resitance mutations in HIV-1 patients failing antiretroviral regimens containing RT, PR or Integrase inhibitors.
Identify transmitted drug resistance mutations in the RT, PR or integrase genes in treatment-naive patients prior to initiation of antiretroviral therapy
Custom Panel: No

PRODUCTION SCHEDULE

Turn Around Time: 5 to 10 days
Days Performed: Monday, Tuesday, Wednesday, Thursday, Friday, Saturday
Sites Performed: Quest Diagnostic Infectious Disease
PHL Test Code: HIVGE
EPIC Test Code: IMO5040
Send Out Test Code: 91692
CPT Coding: 87900, 87901, 87906

Go back to the top of the page.